XML 40 R28.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue (Tables)
 9 Months Ended
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table presents the approximate percentage of our net sales by market group:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2024202320242023
Biologics
40 %
40 %
38 %
37 %
Generics
 18 %
19 %
17 %
20 %
Pharma
23 %
22 %
25 %
24 %
Contract-Manufactured Products
19 %
19 %
20 %
19 %
100 %
100 %
100 %
100 %

The following table presents the approximate percentage of our net sales by product category:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2024202320242023
High-Value Product ("HVP") Components
45 %
50 %
46 %
50 %
High-Value Product ("HVP") Delivery Devices
16 %
11 %
12 %
10 %
Standard Packaging
20 %
20 %
22 %
21 %
Contract-Manufactured Products
19 %
19 %
20 %
19 %
100 %
100 %
100 %
100 %
The following table presents the approximate percentage of our net sales by geographic location:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2024202320242023
Americas
48 %
46 %
44 %
45 %
Europe, Middle East, Africa
44 %
46 %
47 %
46 %
Asia Pacific
8 %
8 %
9 %
9 %
100 %
100 %
100 %
100 %
Schedule of Change in Contract with Customer, Asset and Liability
The following table summarizes our contract assets and liabilities:
($ in millions)
Contract assets, December 31, 2023
$21.5 
Contract assets, September 30, 2024
42.3 
Change in contract assets - increase (decrease)$20.8 
Deferred income, December 31, 2023
$(53.9)
Deferred income, September 30, 2024
(53.8)
Change in deferred income - decrease (increase)$0.1